Crystagen (EDP) – 20mg | Research Compound

Crystagen – 20mg | Research Compound

Crystagen is a synthetic tripeptide with the amino acid sequence Glu-Asp-Pro (EDP), developed within the Khavinson peptide research program. It is studied in laboratory settings for its molecular characteristics, gene-expression interactions, and related cellular signaling pathways.

Key Research Areas:

• Gene-Expression Research — Laboratory investigation of Crystagen-associated gene-expression patterns and molecular regulatory processes.
• Cellular Signaling Research — Laboratory characterization of molecular signaling pathways associated with Crystagen.
• Protein & Cytokine Signaling Research — Investigation of molecular pathways involving heat-shock proteins, cytokine-associated signaling, and related cellular processes.
• Comparative Peptide Research — Comparative investigation of Crystagen and structurally related short-chain peptide bioregulators.

Product Specifications:

• Sequence: Glu-Asp-Pro (EDP)
• Molecular Weight: ~345 Da (confirm against batch-specific COA)
• 20mg lyophilized research compound per vial
• ≥99% purity via HPLC
• Third-party COA available
• Store under appropriate controlled laboratory conditions and protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic.